Efficacy Study Comparing 0.9 g and 1.25 g EstroGel?? 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause.

Trial Profile

Efficacy Study Comparing 0.9 g and 1.25 g EstroGel?? 0.03% Doses With Placebo in the Treatment of Vasomotor Symptoms and Vulvar and Vaginal Atrophy Associated With Menopause.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Apr 2010

At a glance

  • Drugs Estradiol (Primary)
  • Indications Menopausal syndrome
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories; ASCEND Therapeutics
  • Most Recent Events

    • 12 Oct 2006 Status change
    • 27 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top